Back to results

University of Missouri--Columbia

Inhibition of progestin-induced VEGF in mammary cancer by curcumin and 2-methoxy estradiol and their potential role as anti-angiogenic & chemopreventive compounds

Abstract

dc:description.abstract

Estrogen/Progestin combined hormone replacement therapy (HRT) is commonly prescribed to alleviate the symptoms of menopause in women. Combination HRT however is associated with an increased risk of breast cancer, an effect that has been attributed to the progestin component, the most common of which is medroxyprogesterone acetate (MPA). It is likely that breast cancers arise due to progestin-dependent release, from breast tumor cells, of vascular endothelial growth factor (VEGF), a potent angiogenic growth factor. In the present study I show that curcumin, a turmeric root derivative, and 2-methoxyestradiol (2ME2), a natural metabolite of estradiol, effectively inhibit progestin-induced VEGF secretion from breast cancer cells in vitro. Furthermore, curcumin delays progestin-accelerated DMBA-induced tumorigenesis in Sprague-Dawley rats. 2ME2 inhibits hypoxia inducible factor -1{alpha} (HIF-1[alpha]) and also prevents progestin-dependent VEGF release from tumor cells, suggesting that HIF-1[alpha] is an essential transcription factor for mediating the effects of progestins on VEGF elaboration. YC-1, a specific HIF-1[alpha] inhibitor, blocks both the progression of DMBA-induced progestin-accelerated mammary tumors in Sprague-Dawley rats and progestin-dependent human breast cancer xenografts in nude mice, confirming the importance of HIF-1[alpha] in progestin-dependent VEGF release from tumor cells. YC-1 also blocks progestin-induced increases in DNA binding of HIF-1[alpha] to the VEGF promoter in human tumor cells. We conclude that curcumin, 2ME2 and YC-1 show promise as chemotherapeutic and chemopreventive compounds for hormone-dependent mammary cancers.

Degree

thesis:*
Name thesis:degree_name
Ph. D.
Level thesis:degree_level
Doctoral
Discipline thesis:degree_discipline
Veterinary biomedical sciences (MU)
Grantor dc:publisher
University of Missouri--Columbia
Year dc:date.issued
2009

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Carroll, Candace E.
Advisor dc:contributor.advisor
  • Hyder, Salman M.

Rights

dc:rights
Statement dc:rights
  • OpenAccess.
Language dc:language.iso
eng, English

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:mospace.umsystem.edu:10355/10296

Chain of custody

source
Harvested from
University of Missouri
Base URL
mospace.umsystem.edu/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Carroll, Candace E.. Inhibition of progestin-induced VEGF in mammary cancer by curcumin and 2-methoxy estradiol and their potential role as anti-angiogenic & chemopreventive compounds. Doctoral thesis, University of Missouri--Columbia, 2009. https://hdl.handle.net/10355/10296